ask="N/A"
ask_size="N/A"
average_daily_volume="39397"
bid="14.63"
bid_size="500"
book_value="5.83"
change="+0.87"
change_from_200_day_moving_average="-4.13"
change_from_50_day_moving_average="-2.53"
change_from_52_week_high="-11.63"
change_From_52_week_low="4.71"
change_in_percent="+6.28%"
close="14.73"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="7054000"
high="14.95"
high_52_weeks="26.36"
last_trade_date="3/1/2017"
last_trade_price="14.73"
last_trade_size="1314"
last_trade_time="4:00pm"
low="13.84"
low_52_weeks="10.02"
market_capitalization="246.20M"
moving_average_200_day="18.86"
moving_average_50_day="17.26"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="14.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-21.89%"
percent_change_from_50_day_moving_average="-14.66%"
percent_change_from_52_week_high="-44.12%"
percent_change_from_52_week_low="+47.01%"
previous_close="13.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.38"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="7.43"
stock_exchange="NGM"
symbol="PTGX"
volume="81281"
weeks_range_52="10.02 - 26.36"
